These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38829948)

  • 1. The impact of MELD exception points for hydrothorax on posttransplant mortality: a propensity score-matched analysis.
    Fathma S; Boateng S; Amatya A; Ameyaw P; Banini BA
    Eur J Gastroenterol Hepatol; 2024 Aug; 36(8):1016-1021. PubMed ID: 38829948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
    Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
    Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
    Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW
    Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable Use of Model for End-Stage Liver Disease Exception Points in Patients With Neuroendocrine Tumors Metastatic to the Liver and Its Impact on Patient Outcomes.
    Nobel YR; Goldberg DS
    Transplantation; 2015 Nov; 99(11):2341-6. PubMed ID: 25989503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality Risk Factors Among Patients With Cirrhosis and a Low Model for End-Stage Liver Disease Sodium Score (≤15): An Analysis of Liver Transplant Allocation Policy Using Aggregated Electronic Health Record Data.
    Atiemo K; Skaro A; Maddur H; Zhao L; Montag S; VanWagner L; Goel S; Kho A; Ho B; Kang R; Holl JL; Abecassis MM; Levitsky J; Ladner DP
    Am J Transplant; 2017 Sep; 17(9):2410-2419. PubMed ID: 28226199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of Waitlist Mortality in Portopulmonary Hypertension.
    DuBrock HM; Goldberg DS; Sussman NL; Bartolome SD; Kadry Z; Salgia RJ; Mulligan DC; Kremers WK; Kawut SM; Krowka MJ; Channick RN
    Transplantation; 2017 Jul; 101(7):1609-1615. PubMed ID: 28207639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma.
    Goldberg D; French B; Abt P; Feng S; Cameron AM
    Liver Transpl; 2012 Apr; 18(4):434-43. PubMed ID: 22271656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the hepatopulmonary syndrome MELD exception policy on outcomes of patients after liver transplantation: an analysis of the UNOS database.
    Goldberg DS; Krok K; Batra S; Trotter JF; Kawut SM; Fallon MB
    Gastroenterology; 2014 May; 146(5):1256-65.e1. PubMed ID: 24412528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
    Kwong AJ; Lai JC; Dodge JL; Roberts JP
    Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.
    Taniguchi M
    Clin Transpl; 2012; ():41-65. PubMed ID: 23721009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of model for end-stage liver disease exceptions for donation after cardiac death graft recipients relisted for liver transplantation.
    Maduka RC; Abt PL; Goldberg DS
    Liver Transpl; 2015 Apr; 21(4):554-60. PubMed ID: 25597393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation.
    Raza MH; Kwon Y; Kobierski P; Misra AC; Lim A; Goldbeck C; Etesami K; Kohli R; Emamaullee J
    Liver Transpl; 2023 Feb; 29(2):134-144. PubMed ID: 35876731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validating a novel score based on interaction between ACLF grade and MELD score to predict waitlist mortality.
    Abdallah MA; Kuo YF; Asrani S; Wong RJ; Ahmed A; Kwo P; Terrault N; Kamath PS; Jalan R; Singal AK
    J Hepatol; 2021 Jun; 74(6):1355-1361. PubMed ID: 33326814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic encephalopathy is associated with significantly increased mortality among patients awaiting liver transplantation.
    Wong RJ; Gish RG; Ahmed A
    Liver Transpl; 2014 Dec; 20(12):1454-61. PubMed ID: 25155379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Associated with Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver Transplantation.
    Sundaram V; Jalan R; Wu T; Volk ML; Asrani SK; Klein AS; Wong RJ
    Gastroenterology; 2019 Apr; 156(5):1381-1391.e3. PubMed ID: 30576643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver Transplantation for Hepatic Epithelioid Hemangioendothelioma Is Facilitated by Exception Points With Acceptable Long-term Outcomes.
    Brahmbhatt M; Prenner S; Bittermann T
    Transplantation; 2020 Jun; 104(6):1187-1192. PubMed ID: 31577674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.
    Salvalaggio PR; Afonso RC; Pereira LA; Ferraz-Neto BH
    Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Model for End-Stage Liver Disease (MELD) score in predicting outcomes for lower extremity bypass.
    Krafcik BM; Farber A; Eslami MH; Kalish JA; Rybin D; Doros G; Shah NK; Siracuse JJ
    J Vasc Surg; 2016 Jul; 64(1):124-30. PubMed ID: 26994957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of the Model of End-Stage Liver Disease Score in Predicting Outcomes of Carotid Endarterectomy.
    Krafcik BM; Farber A; Eslami MH; Kalish JA; Rybin D; Doros G; King EG; Siracuse JJ
    Vasc Endovascular Surg; 2016 Aug; 50(6):380-4. PubMed ID: 27334479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.
    Schwartz JJ; Pappas L; Thiesset HF; Vargas G; Sorensen JB; Kim RD; Hutson WR; Boucher K; Box T
    Liver Transpl; 2012 Apr; 18(4):423-33. PubMed ID: 22250078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.